Life Science REIT plc (LON:LABS – Get Free Report) shares were down 0.5% on Tuesday . The stock traded as low as GBX 36.70 ($0.46) and last traded at GBX 36.70 ($0.46). Approximately 321,672 shares changed hands during mid-day trading, a decline of 21% from the average daily volume of 409,043 shares. The stock had previously closed at GBX 36.90 ($0.46).
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on LABS shares. Berenberg Bank restated a “buy” rating and set a GBX 57 ($0.71) target price on shares of Life Science REIT in a research note on Thursday, October 3rd. Shore Capital restated a “buy” rating on shares of Life Science REIT in a report on Thursday, September 26th.
View Our Latest Research Report on LABS
Life Science REIT Stock Down 0.5 %
Life Science REIT Company Profile
Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.
Featured Articles
- Five stocks we like better than Life Science REIT
- What is a Secondary Public Offering? What Investors Need to Know
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- What is the Australian Securities Exchange (ASX)
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- The 3 Best Fintech Stocks to Buy Now
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Life Science REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Life Science REIT and related companies with MarketBeat.com's FREE daily email newsletter.
